Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 17, 2011

Vitamin D warning: Too much can harm your heart

  • Misc. MS Related
    /
  • Misc. Research Reports
    /
  • Vitamins and Supplements
    /
By Linda Carroll – msnbc.com contributor –  Nov 16, 2011 When it comes to the heart, vitamin D can be a double-edged…
Misc. MS Related

November 16, 2011

“One Day At a Time” – An MS Patient’s Story –

  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
David Sloan has kept a positive outlook through his struggles with Multiple Sclerosis. Click to listen to: =========================================================== Remain CURRENT with…
An MS Patients Story

November 15, 2011

Learn About Campath-1H, a hopeful new MS medication for 2012

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
In 1975 Cambridge scientists Cesar Milstein and George Kohler at the Laboratory for Molecular Biology (LMB) invented the technology to make large…
MS Drug Therapies

November 15, 2011

A Patient has Questions regarding The Baclofen Pump

  • An MS Patients Story
    /
Hello Stuart Hope you are doing well and that vacation you took went well. I have a question. Do you…
An MS Patients Story

November 14, 2011

Pope Benedict Says “YES” to Adult Stem Cells, No Embryonic

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
November 12, 2011  – Vatican City News Pope Benedict XVI has reaffirmed his opposition to embryonic stem cell research, saying…
Multiple Sclerosis

November 14, 2011

Genzyme Announces Successful Phase III Results for Alemtuzumab (CAMPATH) (LEMTRADA(TM*)) in Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
-Significant efficacy of alemtuzumab over interferon beta-1a (Rebif(R)) observed on both relapse and disability co-primary endpoints in treatment-experienced MS patients…
MS Drug Therapies

November 13, 2011

Acute Multiple Sclerosis – H.P. Acthar® Gel Reduces Shows Promise In Acute Exacerbations

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
A presentation at the American Society of Nephrology 44th Annual Meeting, showed study results of H.P. Acthar® Gel, a natural…
MS Drug Therapies

November 13, 2011

New Medication Research Study begins, to Treat Secondary Progressive MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
Friday, 11 November 2011, 1:40 pm Press Release: Innate Immunotherapeutics Innate Immunotherapeutics Advances Progressive Multiple Sclerosis Study of MIS416 Auckland,…
MS Drug Therapies

November 13, 2011

An ECTRIMS (European Committee for Treatment and Research in MS) and ACTRIMS (Americas Committee for Treatment and Research in MS) WRAP-UP

  • Multiple Sclerosis
    /
  • National MS Society Related
    /
Nov 10, 2011 EXECUTIVE SUMMARY More than 7,000 investigators convened in Amsterdam on October 19-22, 2011 to present findings at…
Multiple Sclerosis

November 9, 2011

MRI Tool Helps to Predict Conversion to Pediatric MS

  • MRI
    /
  • Pediatric MS
    /
AMSTERDAM – An MRI scoring tool helped to identify children with acute central nervous system demyelination who later developed pediatric…
MRI

Categories

Latest Blog Posts